S&P 500 Industrials Sector SEC Filings — May 29, 2026

29-05-2026

Community West Bancshares held its Annual Meeting on May 27, 2026, with 72.23% of outstanding shares represented. All 13 director nominees were elected, and shareholders ratified the appointment of Baker Tilly LLP as independent auditor with overwhelming support (99.9% of votes cast). However, the non-binding advisory resolution on executive compensation received notable opposition, with 876,079 votes against (5.4% of votes cast) and 60,855 abstentions, indicating some shareholder dissent on pay practices.

• · Daniel J. Doyle received the lowest support among director nominees with 12,913,074 votes for and 3,292,881 votes withheld (20.3% withheld).
• · Kirk B. Stovesand also had significant withheld votes: 123,883 against 13,053,991 for (0.9% withheld).
• · All director elections had 3,372,885 broker non-votes, representing about 17.2% of shares represented.
• · The advisory compensation resolution had 15,269,021 votes for, 876,079 against, and 60,855 abstentions, plus 3,372,885 broker non-votes.
• · The auditor ratification had no broker non-votes, with 19,556,109 for, 12,393 against, and 10,338 abstentions.

29-05-2026

On May 28, 2026, Heritage Insurance Holdings, Inc. announced it has fully placed its 2026-2027 indemnity-based catastrophe excess-of-loss reinsurance program for its three insurance subsidiaries. The 8-K filing simply reports this event via a press release; no financial results, performance metrics, or period-over-period comparisons are provided.

• · The reinsurance program covers the 2026-2027 treaty year.
• · The program is catastrophe excess-of-loss and indemnity-based.
• · Subsidiaries covered: Heritage Property Casualty Insurance Company, Narragansett Bay Insurance Company, and Zephyr Insurance Company.
• · No attachment point, limit, or cost details are disclosed in the filing.

29-05-2026

The Trade Desk, Inc. announced that Samantha Jacobson, who resigned as an officer and employee effective May 18, 2026, is now eligible to participate in the non-employee director compensation program. She will receive $50,000 in annual cash compensation and an equity grant of $290,000 (prorated from May 18, 2026) for her service on the board. The transition reflects a change in role from officer to director, with no negative financial impact noted.

• · Samantha Jacobson's resignation as officer and employee was effective May 18, 2026.
• · The equity grant vests in full on the date of the Company's next annual meeting of stockholders.
• · Ms. Jacobson may elect to receive the equity grant in the form of restricted stock, restricted stock units, stock options, or a mix of one-half restricted stock/RSUs and one-half options.

29-05-2026

Quest Water Global, Inc. engaged KAN Accounting Solutions pllc as its new independent accountant on May 27, 2026, replacing Fruci & Associates II, PLLC, which resigned at the company's request on May 5, 2026. The board of directors approved the change. No consultations occurred with KAN regarding accounting principles, audit opinions, disagreements, or reportable events during the fiscal years ended December 31, 2025 and 2024, and through May 27, 2026.

• · Fruci & Associates II, PLLC resigned as independent accountant on May 5, 2026, at the company's request.
• · The company's fiscal years ended December 31, 2025 and 2024, and the period through May 27, 2026, had no consultations with KAN regarding accounting principles, audit opinions, disagreements, or reportable events.
• · Details of Fruci's resignation are referenced in a separate Form 8-K dated May 6, 2026.

29-05-2026

Genesco reported better-than-expected fiscal Q1 2027 results for the three months ended May 2, 2026. Net sales rose 3% to $487M, with total comparable sales up 2%, marking the seventh consecutive quarter of positive comparable sales growth. However, GAAP EPS was ($1.42) and Non-GAAP EPS was ($2.18), while segment performance was mixed with Schuh comparable sales declining 9% and e-commerce growth flat at 0%. The company raised its full-year adjusted EPS outlook to $2.00–$2.40 and announced a new $40–$50M cost savings program through Fiscal 2029.

• · Gross margin improved 30 bps to 47.0% from 46.7%, driven by shipping efficiencies and less promotional activity but partially offset by brand mix.
• · SG&A expenses improved to 52.2% of sales from 52.5%, adjusted SG&A leveraged 60 bps to 51.9%.
• · GAAP operating loss improved to ($15.4M) from ($28.1M) — a 45% reduction in loss.
• · Adjusted operating loss was ($23.9M) vs ($27.9M) last year; adjusted operating margin improved to -4.9% from -5.9%.
• · Schuh total sales decreased 5% (-9% constant currency) due to pullback on promotions.
• · E-commerce comparable sales were flat at 0% vs +7% in prior year — a deceleration.
• · Total comparable sales growth decelerated to 2% from 5% in prior year.
• · Inventory increased 6% YoY, primarily at Journeys.
• · Capital expenditures were $15M, D&A was $13M.
• · Full-year sales guidance: down 1% to flat, reflecting store closures and license exits.
• · Full-year EPS guidance raised to $2.00–$2.40 (midpoint $2.20) from $1.90–$2.30 (midpoint $2.10).
• · Expected tariff refunds of $23–$25M not included in guidance.
• · No share repurchases in Q1 FY27; $29.8M remaining on authorization.
• · Adjusted tax rate for Q2 and Q3 expected in range of 7%–8% due to valuation allowance; full-year tax rate guidance 30%.

29-05-2026

Bandwidth Inc. (BAND) held its 2026 Annual Meeting on May 28, 2026, with 87.08% of eligible votes represented. Stockholders elected David A. Morken and Rebecca G. Bottorff as Class III directors, ratified Ernst & Young LLP as auditors with overwhelming support (99.6% 'For'), and approved say-on-pay and say-on-frequency proposals. However, director elections showed notable opposition, with 18.1% withheld for Morken and 22.2% for Bottorff, and say-on-pay received 24.5% 'Against' votes, indicating significant shareholder dissent on compensation and board composition.

• · The company will hold future advisory votes on executive compensation annually until at least the 2032 annual meeting.
• · Record date for voting was April 1, 2026.
• · Class B common stockholders had 10 votes per share; Class A had 1 vote per share.
• · Proposal 3 (say-on-pay) passed with 30,884,728 For vs 10,011,929 Against (74.1% approval, excluding abstentions).
• · Proposal 4 (say-on-frequency) received a 3-year interval preference as the least popular choice (1,526,775 votes), while 'Every Year' had dominant support.
• · Auditor ratification passed with 43,322,421 For (99.6% of votes cast).

29-05-2026

On May 29, 2026 Spire Global, Inc. (SPIR) announced that Chief Operating Officer Celia Pelaz informed the company she will resign effective September 30, 2026 to pursue a role with another organization. The company does not intend to replace the COO role and has initiated a search for a Chief Commercial Officer consistent with its 2026 strategic priorities; the filing states the resignation was not due to any disagreement about operations, policies, practices, financial reporting or controls.

• · Resignation notice date: May 29, 2026
• · Effective resignation date: September 30, 2026
• · Company telephone: (202) 301-5127
• · Registrant address: 8000 Towers Crescent Drive, Suite 1100, Vienna, Virginia 22182
• · Company will initiate search for a Chief Commercial Officer and does not currently intend to replace the COO role

29-05-2026

VERAXA Biotech strengthened its financial position for its business combination with Voyager Acquisition Corp. by securing a $27.5M senior secured note from an institutional investor and entering into a $50M at-the-market share purchase agreement with Lincoln Park Capital. The transactions provide flexible capital to advance its pipeline of BiTAC-TCE and BiTAC-ADC cancer therapies toward clinical development and initial value inflection points.

• · The Note is a senior secured obligation of VERAXA, secured by all VERAXA assets and ranking senior to all unsecured indebtedness.
• · Any amortization payment under the Note may be made in cash, in registered-for-resale shares of common stock, or a combination thereof, at VERAXA's sole option.
• · The holder of the Note has the right to require VERAXA to redeem up to 20% of the gross proceeds of any future equity or equity-linked financing (cash sweep).
• · VERAXA may redeem the Note at par at any time without penalty, subject to certain conditions.
• · The SPA with LPC contains no warrants, rights of first refusal, or participation rights, and LPC agreed not to engage in any short selling or hedging of VERAXA common stock.
• · The business combination agreement with Voyager was entered into on April 22, 2025, and a proxy statement/prospectus was filed with the SEC on February 19, 2026.

29-05-2026

Faraday Future Intelligent Electric Inc. (FFAI) announced a strategic partnership with Sequoia Education Center, a leading K-12 education group in North America, and signed a sales contract for 23 FF EAI robots, its largest robot order to date. The company also delivered a Master humanoid robot to a medical institution in Los Angeles, marking its first healthcare use case. At the annual stockholders' meeting on May 22, 2026, all proposals received roughly 80% approval support. However, the filing also highlights ongoing risks including the company's ability to continue as a going concern, lack of sufficient share capital, and potential Nasdaq delisting if the stock price falls to $0.10 or less for 10 consecutive trading days.

• · The company has delivered a Master humanoid robot to a medical institution in Los Angeles, its first healthcare use case.
• · FF's collaboration with RobotShop is progressing smoothly, and several major North American e-commerce platforms have expressed interest in partnering on robotics sales.
• · The EAI Brain and Skills ecosystem has developed dozens of Skills covering education, security, reception, guided tours, and companion services.
• · The developer platform includes six major tools; two (BrainBlocks and EAI Soul) are already completed, with the remaining tools rolling out later in May 2026.
• · Decentralized real-world robot data collection is expected to be completed in June 2026.
• · The company faces risks including potential Nasdaq delisting if the stock price falls to $0.10 or less for 10 consecutive trading days, and the need for substantial additional funding to execute its FX strategy.

29-05-2026

Treasure Global Inc (TGL) entered into a Subscription Agreement with Legacy Trustee Berhad on May 26, 2026, for a private placement of $1.2M in common stock, structured as four equal tranches of $300,000 each due by June 23, 2026. The shares are priced at the greater of $3.88 per share or the closing price prior to each tranche's completion date, and the company must file a resale registration statement within 60 days. The agreement is governed by Malaysian law and includes binding, irrevocable commitments from the investor with no financing contingencies.

• · The shares are 'restricted securities' under the Securities Act and subject to Rule 144 resale limitations.
• · The company must use commercially reasonable efforts to maintain the registration statement's effectiveness for up to two years or until all shares are sold or can be sold under Rule 144 without limitations.
• · Each party has agreed to indemnify the other for losses arising from breaches of warranties or misrepresentations.
• · If the investor fails to pay, the company can terminate the agreement and cancel all issued shares; if the company fails to transfer shares, the investor can terminate.
• · The agreement is governed by Malaysian law with jurisdiction in Malaysian courts.

29-05-2026

Edesa Biotech, Inc. held its 2026 Annual General and Special Meeting on May 27, 2026, with approximately 55% of outstanding shares represented. Shareholders approved all four proposals, including the election of seven directors, an advisory vote on executive compensation, an amendment to the 2019 Equity Incentive Compensation Plan to increase available shares by 750,000 and eliminate the annual per-participant option grant limit, and the appointment of MNP LLP as auditors for fiscal 2026. However, the relatively low voter turnout (55%) and notable withhold votes on certain directors (e.g., Carlo Sistilli with 81,096 withhold votes) indicate some shareholder dissent.

• · The meeting was held on May 27, 2026, and the report was filed on May 29, 2026.
• · All seven director nominees were elected, but Carlo Sistilli received the highest number of withhold votes (81,096), followed by David Liu (80,534) and Sean MacDonald (80,738).
• · The advisory vote on executive compensation passed with 2,670,075 for, 69,281 against, and 15,464 abstentions.
• · The Plan Amendment was approved with 2,613,551 for, 130,589 against, and 10,680 abstentions.
• · The appointment of MNP LLP as auditors was approved with 4,814,478 for and 87,443 withhold votes (no broker non-votes).
• · The company is incorporated in British Columbia, Canada, and its common shares trade on Nasdaq under the symbol EDSA.

29-05-2026

Avis Budget Group appointed Tina Goldenberg as Vice President and Chief Accounting Officer, effective June 15, 2026, succeeding Cathleen DeGenova who is retiring. Ms. DeGenova will remain as Senior Vice President and Chief Accounting Officer until June 14, 2026, and will advise the Company through April 1, 2027. Ms. Goldenberg will receive an annual base salary of $270,000 and is eligible for an annual incentive award at a target rate of 45% of base salary.

• · Ms. Goldenberg, age 42, has been a Senior Director overseeing Accounting for the Company’s Americas region since March 2020.
• · She joined the Company in March 2013 and previously held roles in Internal Reporting and Financial Reporting & Technical Accounting.
• · Prior to joining Avis Budget, Ms. Goldenberg was an accountant with Deloitte and is a Certified Public Accountant.
• · Cathleen DeGenova will continue to advise the Company through April 1, 2027, to assist with the orderly transition.

29-05-2026

Otis Worldwide Corporation held its 2026 Annual Meeting of Shareholders on May 27, 2026, with a quorum of 345,588,993 shares (89.6% of outstanding common stock) represented. All ten director nominees were elected, and the advisory vote on executive compensation was approved with 300.6M votes in favor. However, a shareholder proposal on reporting political contributions was not approved, receiving only 145.4M votes for versus 173.4M against. The appointment of PricewaterhouseCoopers as independent auditor for 2026 was overwhelmingly approved with 344.8M votes in favor.

• · The meeting had a quorum of 345,588,993 out of 385,710,610 shares outstanding (89.6%).
• · Director Judith F. Marks received the least support with 306,737,433 votes for and 12,890,163 against, plus 1,564,739 abstentions.
• · The advisory say-on-pay proposal was approved with 300,604,166 votes for (93.8% of votes cast, excluding abstentions).
• · Auditor ratification received nearly unanimous support: 344,841,469 votes for, only 450,913 against.
• · A shareholder proposal on political contributions was rejected: 145,402,369 for, 173,399,850 against (45.6% support).
• · All director nominees were elected with majority support, but several had notable opposition: Nelda J. Connors (10.4M against), Thomas A. Bartlett (9.8M against), Shelley Stewart, Jr. (9.1M against).

29-05-2026

FingerMotion, Inc. reported a 32% decline in total revenue to $24.1M for the fiscal year ended February 28, 2026, compared to $35.6M in the prior year. The net loss attributable to stockholders widened to $7.0M from $5.1M, driven primarily by a sharp drop in Telecommunication Products & Services revenue (-32%) and Marketplace Platform revenue (-69%). The company continues to face regulatory risks related to dividend repatriation and foreign exchange controls in China, while pursuing growth through data analytics and AI-driven platforms.

• · The company faces dividend restrictions under PRC regulations, which may limit its ability to repatriate profits from its WFOE.
• · Foreign exchange controls in China could delay or limit the conversion of RMB into foreign currencies for dividend remittance.
• · The company's corporate partners span airlines, insurance, financial services, e-commerce, and consumer markets, helping to diversify revenue and minimize seasonal fluctuations.
• · The company is working closely with telecommunication operators in select provinces to negotiate better bulk purchase pricing.
• · The Data & Analytics Platform Solutions segment turned positive from a negative revenue base of ($58,209) to $27,780, a 148% improvement, though the absolute amount remains very small.
• · The company plans to further develop the Sapientus Platform to expand data processing capabilities and analytical modeling across various industry verticals.

29-05-2026

Kentucky First Federal Bancorp (KFFB) announced that its Board of Directors will hold a special meeting on July 28, 2026 to consider resuming a quarterly dividend of up to $0.10 per share, after suspending dividends since November 2023. However, the Board may declare a lower dividend or none at all, and no final decision has been made. The dividend resumption is contingent on First Federal MHC (holding 58.5% of shares) waiving its right to receive dividends aggregating up to $0.40 per share over 12 months, and on non-objection from the Federal Reserve Bank of Cleveland.

• · Dividends were suspended on January 16, 2024, and no dividend has been paid since November 2023.
• · First Federal MHC previously approved similar dividend waiver proposals from 2012 through 2023.
• · The special Board meeting on July 28, 2026 will follow the First Federal MHC member meeting to vote on the waiver proposal.
• · Any dividend declaration remains subject to non-objection from the Federal Reserve Bank of Cleveland.

29-05-2026

Bain Capital Private Credit declared a regular distribution of $0.1875 per share for Class I shares, payable on June 30, 2026. As of April 30, 2026, the fund reported an aggregate NAV of $1,039.0 million and a NAV per share of $25.87, with a debt-to-equity ratio of 1.20x. The investment portfolio was valued at $2,076.9 million across 171 companies, with 88% in first lien senior secured debt and 93% of debt investments at floating rates.

• · The distribution of $0.1875 per share will be paid in cash or reinvested under the distribution reinvestment plan.
• · Net debt-to-equity ratio (excluding cash and unsettled trades) was approximately 0.99x as of April 30, 2026.
• · Portfolio composition includes 1% second lien senior secured debt, 5% subordinated debt, 2% preferred equity, 2% common equity, and 2% in an investment vehicle.
• · Total shares issued and outstanding as of May 1, 2026: 40,938,335 Class I shares.

29-05-2026

Triumph Financial, Inc. announced a quarterly cash dividend of $17.81 per share on its 7.125% Series C Fixed-Rate Non-Cumulative Perpetual Preferred Stock (equivalent to $0.44525 per depositary share). The dividend is payable on June 30, 2026 to shareholders of record on June 15, 2026. This filing contains no performance metrics or period-over-period comparisons.

29-05-2026

LyondellBasell Industries N.V. (LYB) entered into the Eighth Amendment to its Receivables Purchase Agreement, effective June 26, 2026, which refinances the facility by paying off MUFG Bank, Ltd. and Gotham Funding Corporation, replacing SMBC Nikko Securities America, Inc. with Sumitomo Mitsui Banking Corporation as Purchaser Agent, and amending the agreement terms. The amendment maintains the existing facility structure with Mizuho Bank, Ltd. as Administrator and LC Bank, and no termination events or defaults were reported.

• · The amendment is effective June 26, 2026, though signed on May 29, 2026.
• · MUFG Bank, Ltd. and Gotham Funding Corporation are being paid off and removed from the agreement.
• · SMBC Nikko Securities America, Inc. assigns its role as Purchaser Agent to Sumitomo Mitsui Banking Corporation.
• · No Termination Event or Unmatured Termination Event exists before or after the amendment.
• · The original Receivables Purchase Agreement was dated September 11, 2012, and this is the eighth amendment.

29-05-2026

Benitec Biopharma appointed David Friedman as a Class III director effective May 22, 2026, granting him options to purchase 35,000 shares under the 2020 Equity Plan. Concurrently, Megan Boston resigned from the Board as part of a governance review but remains CFO and secretary; her departure was not due to any dispute.

• · David Friedman appointed as Class III director with term until 2028 annual meeting.
• · Options vest fully on the earlier of immediately prior to the next annual meeting or first anniversary of Grant Date (May 26, 2026).
• · Megan Boston had been a Board member since 2016; her resignation is effective May 22, 2026.
• · No material transactions involving Friedman or his immediate family requiring disclosure under Item 404(a).

29-05-2026

Rhythm Pharmaceuticals filed a DEFA14A supplement to its definitive proxy statement to clarify beneficial ownership tables as of May 22, 2026. The filing shows that entities affiliated with RA Capital Management (9.7%), Baker Bros. Advisors (8.2%), and BlackRock (6.4%) are the largest institutional holders, while all executive officers and directors as a group own 5.9% of common stock. No negative or flat performance metrics are present in this filing.

• · The filing is a supplement to the definitive proxy statement filed on April 29, 2026, making clarifying changes to the beneficial ownership table.
• · RA Capital Management entities hold 6,666,837 shares (9.7%), the largest 5% holder.
• · Baker Bros. Advisors hold 5,604,483 shares (8.2%) but also hold convertible preferred stock that would add 1,249,998 shares if converted, subject to a 4.99% conversion blocker.
• · Perceptive Advisors hold 3,519,626 shares (5.0%) including shares issuable upon conversion of convertible preferred stock, subject to a 9.99% conversion blocker.
• · All executive officers and directors as a group beneficially own 4,252,902 shares (5.9%), consisting of 535,241 shares of common stock, 3,689,656 shares underlying options exercisable within 60 days, and 28,005 restricted stock units vesting within 60 days.

29-05-2026

Kiniksa Pharmaceuticals held its Annual Meeting on May 29, 2026, where all eight proposals were approved by shareholders. All three Class II director nominees (Stephen R. Biggar, G. Bradley Cole, and Barry D. Quart) were re-elected, and the appointment of PricewaterhouseCoopers LLP as both UK statutory auditor and US independent registered public accounting firm was ratified. However, Stephen R. Biggar received significant opposition with 11,999,916 votes against (24.2% of votes cast), indicating notable shareholder dissent compared to the other director nominees.

• · Record date for voting was April 6, 2026.
• · Each Class A Share entitled to one vote; each Class B Share entitled to ten votes.
• · Proposal 5 (receive UK statutory annual accounts) had 300,415 abstentions, the highest abstention count among all proposals.
• · Proposal 4 (authorize board to determine PwC's UK remuneration) passed with 53,890,585 FOR votes, the highest FOR count among all proposals.
• · Proposal 6 (advisory approval of UK Directors' Remuneration Report) had 1,104,811 votes AGAINST, the second-highest opposition after Stephen R. Biggar's election.

29-05-2026

PEOPLES BANCORP INC (PEBO) filed an S-4 registration statement on May 29, 2026, in connection with its proposed merger with Citizens, where Citizens shareholders will receive 2.10 Peoples common shares and $8.00 in cash per Citizens share. The filing highlights significant risks, including potential difficulties integrating Citizens' operations, loss of key employees, and the limited market for Citizens' OTC-traded shares, which may affect the fairness assessment. Former Citizens shareholders are expected to own approximately 5.4% of the combined company, reducing their influence, and the merger is subject to a $3 million termination fee if Citizens pursues an alternative acquisition.

• · The Exchange Ratio is fixed at 2.10 Peoples shares per Citizens share, subject to customary anti-dilution adjustments and a potential increase if Peoples' stock price declines relative to the Nasdaq Bank Index.
• · Citizens' common shares trade on the OTC market with limited and sporadic volume, making market price an unreliable indicator of fair value.
• · The fairness opinion from Hovde is dated April 20, 2026, and does not reflect changes after that date.
• · The merger agreement restricts Citizens from soliciting alternative proposals and requires a $3 million termination fee under certain conditions.
• · If the merger fails, Citizens may face negative reactions from customers and employees, and litigation risks.

29-05-2026

CCC Intelligent Solutions Holdings Inc. filed an 8-K/A to disclose compensation arrangements for Rodney Christo, who was appointed Interim Chief Financial Officer following Brian Herb's resignation. Christo's base salary increases to $425,000 per year for a transition period, and he is eligible for a one-time transition cash bonus between $125,000 and $200,000, contingent on the length of the transition and successful onboarding of a successor CFO. The filing does not include any financial performance data, so no period-over-period comparisons are available.

• · The transition period begins on May 25, 2026 and continues until a successor CFO is appointed and onboarded.
• · The transition bonus is payable in a lump sum on the first payroll date after the earlier of the end of the transition period or December 31, 2026.
• · The transition bonus is forfeited if Christo's employment is terminated by the company for cause or by him without good reason before the payment date.
• · Christo will continue to serve as Chief Accounting Officer while serving as Interim CFO.

29-05-2026

urban-gro, Inc. filed a definitive additional proxy statement (DEFA14A) on May 29, 2026, supplementing its proxy statement for the Special Meeting of Shareholders scheduled for June 3, 2026. The sole purpose of the supplement is to correct the number of outstanding shares of common stock entitled to vote, updating it to 1,404,499 as of the record date of May 6, 2026. This correction does not alter any other proxy materials or voting instructions; shareholders who already voted need not take further action.

• · The special meeting will be held on June 3, 2026.
• · Shareholders are allowed one vote per share of common stock.
• · Any previously requested proxy cards remain valid and unchanged.
• · Shareholders who have not yet voted are urged to vote using the methods described in the original proxy statement.

29-05-2026

First Interstate BancSystem, Inc. filed a Certificate of Amendment to its Certificate of Incorporation, effective May 28, 2026, to change the standard for electing directors from plurality voting to majority voting, except in contested elections where plurality voting will still apply as set forth in the Bylaws. The amendment was approved by the Board on February 24, 2026, and subsequently ratified by shareholders at the 2026 Annual Meeting. No financial figures or period-over-period comparisons are included in this filing.

• · The amendment was adopted by the Board on February 24, 2026, and approved by shareholders at the 2026 Annual Meeting.
• · Majority voting applies to director elections except in contested elections, where plurality voting will be used as defined in the Bylaws.
• · Cumulative voting for directors is explicitly prohibited.
• · The amendment became effective upon filing with the Delaware Secretary of State on May 28, 2026.

29-05-2026

Hertz Global Holdings held its 2026 Annual Meeting on May 28, 2026, where shareholders elected two director nominees—Lucy Clark Dougherty and Evangeline Vougessis—to the Board for terms ending in 2029. Shareholders also ratified Ernst & Young as the independent auditor for FY 2026 and approved, on an advisory basis, executive compensation. Notably, the two director nominees received strong majority support, but Evangeline Vougessis had a significantly higher number of withheld votes (25.4M) vs. Lucy Clark Dougherty (2.5M), and broker non-votes were material at ~35.9M for the director elections and the executive compensation vote.

• · Two director positions were up for election; terms until 2029.
• · Evangeline Vougessis received ~25.4M withheld votes (10.9% of votes cast) vs. Lucy Clark Dougherty's ~2.5M (1.1% withheld).
• · Broker non-votes on director elections and executive compensation were ~35.9M, representing a significant portion of total shares not voted on those items.
• · Auditor ratification was a non-broker-non-vote item and passed with ~266.2M For vs. 2.3M Against.
• · Advisory say-on-pay was approved with ~228.3M For vs. 3.9M Against, but broker non-votes were excluded, so only ~232.1M votes were cast on that matter.

29-05-2026

Amerant Bancorp Inc. appointed Adrian Rodriguez as Executive Vice President and Chief Operating Officer, effective May 26, 2026, after he served as Interim COO since November 10, 2025. The compensation terms for his new role have not yet been determined and will be disclosed in a future filing. No family relationships or reportable transactions exist between Mr. Rodriguez and the company's directors or officers.

• · Mr. Rodriguez previously served as Executive Vice President and Head of Loan Operations since 2022, overseeing loan and credit operations, legal documentation, servicing, loan accounting, and regulatory compliance.
• · From 2019 to 2022, he was Senior Vice President and Internal Controls Manager, managing SOX compliance and third-party vendor risk.
• · He earned a BBA in 2007 and an MBA in 2010, both from Florida International University.
• · No arrangements or understandings exist with any other persons regarding his appointment.

29-05-2026

JATT II Acquisition Corp., a SPAC founded on January 13, 2026, reported its first quarterly results for the period ended March 31, 2026. The company has not yet completed a business combination and as an early-stage shell company, it posted a net loss of $68,793 from inception through Q1 2026, entirely driven by general and administrative expenses and offering costs. Total assets were $161,079 against total current liabilities of $204,872, resulting in a negative shareholder's deficit of $43,793, reflecting early-stage capital structure as it ramps up for a target acquisition.

• · Operating expenses (general & administrative) were $68,793 from inception through March 31, 2026, resulting in a net loss of $68,793 (EPS of -$0.05 per share).
• · The company has zero cash on hand as of March 31, 2026, and relies on a related-party promissory note ($106,141) for working capital.
• · Up to 225,000 of the 1,725,000 founder shares are subject to forfeiture depending on the underwriter's over-allotment option exercise (Note 5).
• · Entity is a shell company, non-accelerated filer, emerging growth company, and listed on NASDAQ under ticker JATT.

29-05-2026

Entravision Communications Corporation (EVC) held its 2026 annual meeting on May 28, 2026, where stockholders elected seven directors, ratified Deloitte & Touche as auditor for FY2026, approved non-binding executive compensation, and approved an amendment to the 2004 Equity Incentive Plan increasing shares authorized by 6,000,000. While the executive compensation advisory vote passed with about 83.5% of votes cast in favor, the equity plan amendment was approved by a narrower margin with only 70.1% of votes cast in favor; director Fehmi Zeko received a relatively high 17.1% withhold vote, indicating some investor dissent.

• · The equity plan amendment was approved with 43,546,376 FOR vs 18,546,733 AGAINST (70.1% in favor of votes cast, excluding broker non-votes).
• · Executive compensation advisory vote: 51,920,969 FOR, 10,171,084 AGAINST, 23,085 abstentions (83.6% in favor of votes cast).
• · Ratification of Deloitte & Touche passed overwhelmingly: 71,402,716 FOR, 158,992 AGAINST, 21,396 abstentions.
• · Director Fehmi Zeko received the highest withhold vote tally among directors: 10,654,102 withheld (17.1% of votes cast, excluding broker non-votes).
• · All other directors received over 97% support among votes cast excluding broker non-votes.

29-05-2026

DigitalBridge Group, Inc. held its 2026 Annual Meeting on May 28, 2026, where all nine director nominees were elected, the advisory vote on executive compensation was approved, and the amendment to the 2024 Omnibus Stock Incentive Plan (adding 6,000,000 shares) was approved. However, the election results showed significant opposition to certain directors, with James Keith Brown, Jeannie H. Diefenderfer, and Gregory J. McCray each receiving over 28 million votes against, and the executive compensation proposal passed with a relatively narrow margin (73.1 million for vs. 48.5 million against), indicating notable shareholder dissent.

• · The advisory vote on executive compensation passed with 73,139,847 votes for and 48,477,618 votes against, a margin of only 60.1% in favor.
• · Director Gregory J. McCray received the highest votes against (35,446,208) among all nominees, with only 82,635,632 votes for.
• · The ratification of Ernst & Young as independent auditor passed overwhelmingly with 147,487,500 votes for and only 726,395 against.
• · The Omnibus Plan amendment was approved with 118,023,425 votes for and 3,924,132 against.
• · 2,358,601 shares of class A common stock were issued in a private placement under Section 4(a)(2) to satisfy an OP unit redemption.

29-05-2026

Nutra Pharma Corp (NPHC) reported a net loss of $459,675 for Q1 2026, a significant improvement from a $1,404,923 loss in Q1 2025, driven by a $140,500 net gain on debt settlement and a much smaller change in fair value of convertible notes ($120,564 vs $1,007,309). However, net sales plunged 63% to $27,246 from $73,974, and gross profit fell 68% to $18,975 from $59,131, while operating expenses remained high at $398,224, leading to a wider operating loss of $379,249 compared to $349,819. The company's total liabilities of $17.9M far exceed total assets of $616,518, resulting in a stockholders' deficit of $17.3M, and cash from operations remains negative at -$327,791.

• · Total liabilities of $17,878,499 exceed total assets of $616,518, resulting in a stockholders' deficit of $17,261,981 as of March 31, 2026.
• · Current liabilities include $9,856,069 in debt (net of discount, current portion) and $2,236,748 in accrued expenses.
• · The company issued 60,000,000 common shares for settlement of debt during Q1 2026.
• · Inventory decreased slightly from $118,705 to $117,296, with long-term inventory of $93,790.
• · Net cash used in operating activities improved to $327,791 from $405,006 in Q1 2025, but remains negative.
• · Cash provided by financing activities was $337,454, down from $408,454 in Q1 2025.
• · The company had no cash paid for income taxes in either period.
• · Depreciation expense was $2,501 for Q1 2026, up from $2,145 in Q1 2025.

29-05-2026

Immix Biopharma, Inc. held its 2026 Annual Meeting on May 22, 2026, where stockholders elected nine directors and ratified Crowe LLP as the independent auditor for the year ending December 31, 2026. All director nominees received strong support, with votes in favor ranging from approximately 34.4M to 35.8M shares; however, director Gabriel Morris received a notable 1.5M 'withheld' votes, the highest among all nominees.

• · Broker non-votes for director elections were 6,445,683–6,445,684 shares per nominee.
• · Ratification of Crowe LLP received 42,276,496 'For', 11,526 'Against', and 18,442 'Abstain' votes, with zero broker non-votes.
• · The meeting was held on May 22, 2026, and the 8-K was filed on May 29, 2026.
• · The company is an emerging growth company and has not elected extended transition for new accounting standards.

29-05-2026

H. Gilbert Culbreth, Jr. resigned from the Board of Seacoast Banking Corporation of Florida effective June 15, 2026, for personal reasons and not due to any disagreement. He will remain on the board of the subsidiary Seacoast National Bank. The company expressed gratitude for his service.

• · Mr. Culbreth was appointed to the Board in 2008 and served on the compensation and governance committee.
• · Resignation effective June 15, 2026.
• · He will remain on the board of Seacoast National Bank.

29-05-2026

Federal Home Loan Bank of Des Moines issued four new consolidated obligations on May 26, 2026, with a total principal amount of $70,000,000. The issuances include one non-callable fixed-rate bond ($25,000,000 at 4.38%) and three optional principal redemption (callable) Bermudan-style fixed-rate bonds totaling $45,000,000, with coupons ranging from 4.00% to 4.45% and maturities from June 2027 to June 2029.

• · All four bonds are Fixed Constant rate type (non-variable).
• · Three of the four bonds are callable (Optional Principal Redemption) with Bermudan call style, meaning redeemable on specified recurring dates after the first call date.
• · The non-callable bond (CUSIP 3130AWN3) matures on June 8, 2029, and has the highest coupon among the issuances at 4.38%.
• · The callable bonds have first call dates ranging from November 2026 to November 2026, and final maturities from June 2027 to May 2029.
• · No variable-rate, amortizing, or indexed bonds were issued in this batch.

29-05-2026

Edible Garden AG Inc. received a Nasdaq delisting notice on May 27, 2026, for failing to meet the minimum $1 bid price requirement for 30 consecutive business days. Due to prior reverse stock splits, the company is ineligible for a standard compliance period and faces suspension on June 5, 2026, unless it successfully appeals. The company intends to request a hearing by June 3, 2026, which would temporarily stay the suspension, but there is no assurance of a favorable outcome.

• · The company has effected a reverse stock split in the prior one-year period or cumulative reverse splits greater than 250:1 in the last two years, making it ineligible for a compliance period.
• · The suspension is scheduled for the opening of business on June 5, 2026, unless a hearing is requested by June 3, 2026.
• · While the appeal is pending, common stock and warrants will continue trading under symbols EDBL and EDBLW.
• · The company's common stock has a par value of $0.0001 per share.

29-05-2026

Actinium Pharmaceuticals (ATNM) received a delisting notice from NYSE American on May 27, 2026, for failing to meet minimum stockholders' equity of $4.0 million, reporting only ~$2.3 million as of March 31, 2026, with net losses in the last five fiscal years. The company must submit a compliance plan by June 26, 2026, and has until November 27, 2027 to regain compliance. However, the company simultaneously announced a positive program update for its ATNM-400 radioconjugate with three presentations at the SNMMI 2026 conference, highlighting its potential as a mutation-agnostic pan-tumor therapy.

• · The company must submit a compliance plan by June 26, 2026, and has until November 27, 2027 to regain compliance.
• · If the plan is not accepted, delisting proceedings will commence.
• · ATNM shares will trade with a '.BC' indicator denoting below compliance.
• · ATNM-400 data to be presented at SNMMI 2026 (May 31-June 2) for prostate cancer and NSCLC models, plus a third poster on radioconjugate optimization.
• · The company holds ~250 patents and patent applications, including cyclotron-based Ac-225 production IP.
• · Net losses reported in each of the last five fiscal years ended December 31, 2025.

29-05-2026

The Gabelli Dividend & Income Trust filed definitive additional proxy materials (DEFA14A) on May 29, 2026, regarding its contested Annual Meeting of Shareholders adjourned to June 29, 2026. The Board unanimously recommends voting the WHITE proxy card for all Board nominees, supported by independent proxy advisory firm Glass Lewis, which noted that Saba has not established a sufficient case for change and that the Fund's total shareholder returns compare favorably to similar funds with a narrowing discount to NAV. The filing also warns that voting the GOLD proxy card from Saba would disenfranchise shareholders from electing a full slate of Trustees.

• · The meeting was originally scheduled for May 11, 2026, and has been adjourned to June 29, 2026.
• · Glass Lewis noted that Mr. Clemot does not appear to have prior experience serving on the board of a closed-end fund or other public company board.
• · The Fund's discount to NAV has been narrowing recently.
• · Saba has nominated only one Hedge Fund Nominee, while four trustees are standing for election.
• · Shareholders who previously submitted a GOLD proxy card may change their vote by submitting a new WHITE proxy card; only the latest dated vote counts.
• · The Board believes Saba may attempt tender offers, changes to the Fund's structure, liquidity events, or short-term measures to monetize discounts.

29-05-2026

Scotiabank announced a definitive agreement to acquire Maple Financial Holdings, Inc., parent company of MapleMark Bank, a U.S. commercial bank primarily operating in Dallas, Texas. The acquisition will enable Scotiabank to offer FDIC deposit insurance to clients, supporting its Mortgage Capital Markets business and deposit growth strategy within the North American corridor. The transaction is not expected to have a material impact on Scotiabank's earnings or CET1 ratio and is subject to customary closing conditions and regulatory approvals.

• · The transaction is not expected to have a material impact on Scotiabank's earnings or CET1 ratio.
• · Scotiabank had approximately $1.5 trillion in assets as at April 30, 2026.
• · The acquisition is subject to customary closing conditions and receipt of regulatory approvals.
• · Scotiabank intends to file a registration statement on Form F-4 with the SEC in connection with the transaction.

29-05-2026

eBay Inc. filed additional proxy soliciting materials (DEFA14A), urging stockholders to vote ahead of the June 17, 2026 annual meeting. The Board recommends voting FOR proposals 1, 2, and 3 and AGAINST stockholder proposal 4, which seeks to lower the special meeting threshold. The company is also proactively reaching out to stockholders to discuss proposal 4 and other governance topics.

• · Annual meeting date: June 17, 2026.
• · Voting methods: internet (www.proxyvote.com), phone (+1-800-690-6903), or mail.
• · Board recommends AGAINST stockholder proposal 4 (lower special meeting threshold).
• · eBay is offering discussions with stockholders between June 1-16, 2026.
• · Materials shared: 2026 proxy statement, latest earnings, 2025 Annual Report, 2025 Impact Report, 2025 Recommerce Report.

29-05-2026

Carter Bankshares, Inc. completed a strategic repositioning of its securities available-for-sale portfolio on May 29, 2026, selling $139.4 million in book value of low-yield securities (2.28% weighted average yield) and purchasing $88.5 million of higher-yielding securities (5.27% weighted average yield) rated AAA or AA. The repositioning is expected to result in a pre-tax loss of approximately $12.5 million in Q2 2026, but the company estimates the loss will be recovered over about 2.98 years and will improve annual interest income by approximately $4.2 million. Remaining proceeds will be used to fund organic loan growth.

• · All purchased securities are rated AAA or AA by a recognized credit rating agency.
• · Remaining proceeds from the repositioning will be used to fund organic loan growth.
• · The pre-tax loss will be included in Q2 2026 financial results.
• · The repositioning involves approximately 18.7% of the company's securities portfolio.

29-05-2026

XCF Global, Inc. (SAFX) announced an additional private placement of 26,666,680 shares of common stock for gross proceeds of $4,000,002, and reported that its New Rise Renewables Reno facility is in the final phase of a planned upgrade, with production restart expected in early June 2026. The company highlighted progress on the facility conversion but also disclosed ongoing risks, including disputes with its landlord and primary lender, and the need to regain Nasdaq compliance.

• · The private placement was conducted under exemption from registration under the Securities Act of 1933.
• · XCF agreed to register the resale of the shares with the SEC in the future.
• · The facility restart is subject to catalyst receipt, final commissioning, and standard start-up procedures.
• · XCF is working to advance expansion opportunities in Nevada, North Carolina, and Florida.
• · The company faces ongoing disputes with its landlord regarding the ground lease for the Reno facility and with its primary lender regarding outstanding loans.
• · XCF is at risk of not meeting Nasdaq continued listing standards.
• · The business combination agreement with DevvStream Corp. and Southern Energy Renewables Inc. is binding but does not obligate consummation; closing conditions remain.

29-05-2026

On May 28, 2026, the Board of Directors of Science Applications International Corp (SAIC) declared a regular quarterly cash dividend of $0.37 per share, payable on July 24, 2026, to stockholders of record on July 10, 2026. This filing serves as the official notification of the dividend declaration and provides the associated press release. The dividend amount and timeline are consistent with SAIC's ongoing shareholder return program.

• · The dividend was declared under Item 8.01 (Other Events) and is accompanied by a press release furnished as Exhibit 99.1.
• · Record date for the dividend is July 10, 2026, and payment date is July 24, 2026.
• · The Company is incorporated in Delaware with fiscal year ending January 30, 2026 (most recent fiscal year noted in header context).

29-05-2026

Axiom Intelligence Acquisition Corp 1 (SPAC) has entered into a definitive Business Combination Agreement dated May 25, 2026, to acquire Terra Quantum AG, a Swiss quantum technology company, through a two-step merger structure. The transaction involves the formation of a Swiss public holding company (PubCo) and a merger of SPAC with a subsidiary, followed by the acquisition merger of Swiss HoldCo into PubCo, with the combined entity expected to be publicly traded. The agreement includes sponsor and shareholder support agreements, lock-up provisions, and an earnout mechanism, but no specific financial terms (e.g., valuation, PIPE size, or trust account balance) are disclosed in this excerpt.

• · The SPAC Board unanimously approved the transaction and deemed it in the best interests of SPAC.
• · Sponsor Support Agreement requires Sponsor to vote in favor, not redeem shares, and not transfer SPAC securities.
• · Shareholder Support Agreements include lock-up provisions for certain PubCo Ordinary Shares post-closing.
• · The transaction is structured to qualify as a tax-free reorganization under Section 368(a)(1)(F) of the U.S. Internal Revenue Code.
• · A Registration Rights Agreement will be entered into at closing among PubCo, Sponsor, SPAC, and certain Swiss HoldCo shareholders.
• · The agreement includes a trust account waiver by the Company and its shareholders.

29-05-2026

FG Merger II Corp. (FGMC) entered into an OTC Equity Prepaid Forward Transaction with Atsion Opportunity Fund LLC and FG Capital Partners LLC (a related party) to provide potential growth capital in replacement of redeemed Trust assets for its business combination with BOXABL Inc. The agreement allows the Seller to purchase up to 3,000,000 shares of FGMC common stock, with a prepayment amount equal to the per-share redemption price, and includes a waiver of redemption rights on those shares. However, the transaction is a related-party arrangement involving FGMC officers/directors, and the forward purchase structure introduces complexity and potential dilution risk.

• · The Forward Purchase Agreement is not intended to meet minimum cash requirements for the initial business combination, but to replace redeemed Trust assets with growth capital.
• · The Seller waived redemption rights on the Shares during the term of the agreement, which could reduce the number of shares redeemed and alter perception of the business combination's strength.
• · The Reference Price of $10.00 may be reduced by the Counterparty one time in any 21-day period.
• · The Cash Settlement Payment Date is the tenth trading day following the Maturity Date, with the Seller remitting an amount equal to (Number of Shares × average VWAP) minus (Number of Shares × $0.80).
• · The Registration Statement on Form S-4 has been declared effective, and a definitive proxy statement/prospectus has been mailed to shareholders.

29-05-2026

Asset Dedication, LLC filed its Form 13F-HR for the quarter ended March 31, 2026, reporting 1,114 positions with total holdings value of approximately $1.43 billion. The portfolio is heavily weighted toward large-cap equities, with top positions including Apple Inc. ($18.2M), Amazon.com Inc. ($7.8M), Broadcom Inc. ($10.5M), and Alphabet Inc. (combined Class A and C ~$10.7M). The filing reflects significant ETF exposure, especially Dimensional Fund Advisors (DFA) products, which account for a large portion of total holdings value.

• · The filing lists 1,114 positions, representing approximately $1.43 billion in total reported holdings.
• · Top individual equity holdings by value include Apple ($18.2M), Amazon ($7.8M), Broadcom ($10.5M), Alphabet Class C ($6.9M), Alphabet Class A ($3.8M), Caterpillar ($8.1M), American Express ($6.6M), Berkshire Hathaway Class B ($4.3M), Coca-Cola ($3.4M), and Costco ($4.5M).
• · Significant ETF positions include Dimensional US Core Equity 2 ETF (4,457,997 shares, ~$173M), Dimensional Emerging Markets Value ETF (2,553,044 shares, ~$91M), Dimensional International Core Equity ETF (2,408,781 shares, ~$86M), Dimensional International Small Cap Value ETF (1,221,023 shares, ~$48M), and Dimensional Emerging Markets Core Equity ETF (2,484,046 shares, ~$86M).
• · Other notable holdings include Boeing ($958K), CVS Health ($100K), ConocoPhillips ($450K), Cummins ($881K), Deere ($1.07M), and Dell Technologies ($704K).
• · The manager listed is Brian Duvall, with a phone number of 415-214-2846, and the filing was signed on May 29, 2026, at Bishop, CA.

29-05-2026

Traws Pharma, Inc. filed a DEFA14A on May 29, 2026, providing additional proxy materials for the upcoming stockholder meeting. Key proposals include the election of seven director nominees, an amendment to the 2021 Incentive Compensation Plan to increase authorized shares by 2,000,000, ratification of KPMG LLP as auditor for FY2026, and approval of the issuance of shares upon exercise of Series B and Series C Warrants issued under an April 15, 2026 Securities Purchase Agreement. The filing notes a request deadline of June 24, 2026, for paper/email copies of materials.

• · Filing is a DEFA14A (additional proxy soliciting material) filed on May 29, 2026.
• · Stockholder meeting adjournment proposal (Proposal 5) included in case sufficient votes not received.
• · Securities Purchase Agreement for warrants was entered into on April 15, 2026.
• · Deadline to request free paper/email copy of proxy materials is June 24, 2026.
• · Voting instructions reference a control number to be included in email requests.

29-05-2026

Apogee Enterprises announced the resignation of Brent C. Jewell as President of its Architectural Glass Segment, effective June 10, 2026. The resignation is unrelated to a transaction announced on May 28, 2026, and is not due to any disagreement with the company. Mr. Jewell will assist with transition and integration activities related to the transaction through his final employment date.

• · Mr. Jewell's last day with the company is June 10, 2026.
• · The resignation is unrelated to the transaction announced on May 28, 2026.
• · Mr. Jewell will support transition, pre-closing, and integration activities related to the transaction through his final date of employment.